Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 126 entries
View as:

Clinical Trial on the Efficacy and Safety of Biodegradable 3D-Printed Implants in Chest Wall Reconstruction Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06977022 Org: User:
Start: 05/31/25 End: 05/31/28 Due: 05/31/29

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05400070 Org: User:
Start: 03/01/21 End: 12/30/26 Due: 12/30/27

TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

Phase: N/A Priority: Normal
NCT ID: NCT04182984 Org: User:
Start: 11/04/19 End: 11/04/24 Due: 11/04/25

Baricitinib for the Lung Injury Following Spontaneous SAH

Phase: N/A Priority: Normal
NCT ID: NCT06439615 Org: User:
Start: 08/01/24 End: 06/30/27 Due: 06/30/28

Effect of Degranulation Needle With Different Diameters on the Rate Good Embryo in IVF

Phase: N/A Priority: Normal
NCT ID: NCT03810040 Org: User:
Start: 02/28/19 End: 11/30/19 Due: 11/30/20

Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR Imaging

Phase: N/A Priority: Normal
NCT ID: NCT03212027 Org: User:
Start: 07/31/17 End: 05/01/18 Due: 05/01/19

PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin Addiction

Phase: N/A Priority: Normal
NCT ID: NCT04086459 Org: User:
Start: 06/01/19 End: 07/01/22 Due: 07/01/23

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Phase: N/A Priority: Normal
NCT ID: NCT06851169 Org: User:
Start: 04/01/25 End: 08/01/27 Due: 08/01/28

Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury

Phase: N/A Priority: Normal
NCT ID: NCT04900168 Org: User:
Start: 06/01/21 End: 06/30/24 Due: 06/30/25

The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders

Phase: N/A Priority: Normal
NCT ID: NCT04274777 Org: User:
Start: 09/21/19 End: 12/21/20 Due: 12/21/21

Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05167604 Org: User:
Start: 09/30/21 End: 12/31/24 Due: 12/31/25

Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06952621 Org: User:
Start: 05/31/25 End: 12/31/28 Due: 12/31/29

Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05387109 Org: User:
Start: 06/30/22 End: 04/20/24 Due: 04/20/25

fMRI Study of the Neural Mechanism of rTMS in the Treatment of Nicotine Dependence

Phase: N/A Priority: Normal
NCT ID: NCT06762535 Org: User:
Start: 04/01/23 End: 08/01/25 Due: 08/01/26

Adebrelimab + Apatinib in SCLC Maintenance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06475209 Org: User:
Start: 06/20/24 End: 12/20/26 Due: 12/20/27

Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT06896747 Org: User:
Start: 02/21/25 End: 03/31/27 Due: 03/31/28

Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane

Phase: N/A Priority: Normal
NCT ID: NCT06644066 Org: User:
Start: 05/01/24 End: 12/30/24 Due: 12/30/25

Study on Cognitive Impairment of Insomnia Based on MRI

Phase: N/A Priority: Normal
NCT ID: NCT05659511 Org: User:
Start: 07/01/22 End: 06/30/24 Due: 06/30/25

Deep Brain Stimulation of Nucleus Accumbens to Treat Severe Anorexia Nervosa

Phase: N/A Priority: Normal
NCT ID: NCT02593695 Org: User:
Start: 10/31/15 End: 12/31/17 Due: 12/31/18

Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06436040 Org: User:
Start: 01/24/24 End: 05/16/25 Due: 05/16/26

Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell

Phase: N/A Priority: Normal
NCT ID: NCT06006650 Org: User:
Start: 08/01/22 End: 12/31/31 Due: 12/31/32

Noninvasively Predicting Gene Status of Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03102112 Org: User:
Start: 01/01/17 End: 03/03/18 Due: 03/03/19

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04840290 Org: User:
Start: 06/01/19 End: 06/01/23 Due: 06/01/24

SP Intravenous Chemotherapy Versus SP by HIPEC in Stage Ⅲ Patients After D2 Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT02396498 Org: User:
Start: 04/30/14 End: 12/31/16 Due: 12/31/17

The Functional Magnetic Resonance Imaging Study on the Processing of Acute Pain and Cognition Among Perimenopause Women

Phase: N/A Priority: Normal
NCT ID: NCT02820974 Org: User:
Start: 11/30/16 End: 12/31/19 Due: 12/31/20